I joined Clearwater in December 2018 to lead M&A advisory within healthcare and life sciences technology and specialist services - including life science commercialisation services, e-clinical solutions, healthcare IT, software and IP driven consultancies. My 21 year career has traversed investment banks, Big Four firms and M&A boutiques and I joined Clearwater for its truly international team, passion for high quality client service, culture and dynamism.
I have spent 16 years in M&A advisory, in the UK and the US, and advised on over 40 transactions across the sell- side, buy-side, owner-managed businesses, large corporates, private equity and public to private transactions. I have also provided extensive Board level advice both pre- and post-deal processes. The healthcare and life science industry, and its increasing technology enablement, has been my main focus throughout. Deals I have advised on include the sales of Age UK’s telecare business to Axa PPP Healthcare, Medaxial to Covance, Abacus International to Decision Resources Group and Synergy to DDB, Omnicom.
I have previously held roles at Deloitte, Results International, Nomura, Royal Bank of Canada and Ernst & Young. I am a Chartered Accountant and hold a BSc in Economics from the London School of Economics.